(Q37120169)

18 August 2017

1 reference

title

Cell vehicle targeting strategies (English)

1 reference

18 August 2017

2

D T Curiel

1 reference

18 August 2017

J C Roth

1

1 reference

PubMed ID

18369326

18 August 2017

L Pereboeva

series ordinal

3

1 reference

18 August 2017

27 March 2008

1 reference

18 August 2017

1 reference

18 August 2017

15

1 reference

18 August 2017

10

1 reference

18 August 2017

716-729

1 reference

https://scigraph.springernature.com/pub.10.1038/gt.2008.38

18 August 2017

0 references

cites work

Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Biodegradable nanoparticles for cytosolic delivery of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Intraperitoneal injection of genetically modified, human mesothelial cells for systemic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Sustained delivery of erythropoietin in mice by genetically modified skin fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Approach to ex vivo gene therapy in the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Genetically engineered stem cells for therapeutic gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

A novel approach to tumor suppression with microencapsulated recombinant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Engineering targeted viral vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Adenovirus tumor targeting and hepatic untargeting by a coxsackie/adenovirus receptor ectodomain anti-carcinoembryonic antigen bispecific adapter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Bone homing of mesenchymal stem cells by ectopic alpha 4 integrin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Synergistic antitumor effects of immune cell-viral biotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Tumor antigen-specific induction of transcriptionally targeted retroviral vectors from chimeric immune receptor-modified T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Antibody engineering, virus retargeting and cellular immunotherapy: one ring to rule them all?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Cellular cardiomyoplasty: routes of cell delivery and retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Transplantation of adult rat spinal cord stem/progenitor cells for spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Repeated direct endomyocardial transplantation of allogeneic mesenchymal stem cells: safety of a high dose, "off-the-shelf", cellular cardiomyoplasty strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Agent-based model of inflammation and wound healing: insights into diabetic foot ulcer pathology and the role of transforming growth factor-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Magnetic resonance fluoroscopy allows targeted delivery of mesenchymal stem cells to infarct borders in Swine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

MR evaluation of the glomerular homing of magnetically labeled mesenchymal stem cells in a rat model of nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

In vivo trafficking and targeted delivery of magnetically labeled stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

21 January 2018

Cell-based drug delivery

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Erythrocyte-based drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Applications of carrier erythrocytes in delivery of biopharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Leukocyte-endothelial cell interactions in the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis(x) oligosaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Chemokines and chemokine receptors in leukocyte trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

T-Cell Function and Migration — Two Sides of the Same Coin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Chemokine control of lymphocyte trafficking: a general overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

T-cell homing specificity and plasticity: new concepts and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Molecular determinants controlling homeostatic recirculation and tissue-specific trafficking of lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Adoptive cell transfer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Adoptive-cell-transfer therapy for the treatment of patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Tumor-derived chemokine MCP-1/CCL2 is sufficient for mediating tumor tropism of adoptively transferred T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Other functions, other genes: alternative activation of antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Preferential involvement of CX chemokine receptor 4 and CX chemokine ligand 12 in T-cell migration toward melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Mouse bone marrow contains large numbers of functionally competent neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Tissue destruction by neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Characteristics and mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Blood monocytes consist of two principal subsets with distinct migratory properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

The macrophage at the crossroads of insulin resistance and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Tumour-associated leucocytes: friends or foes in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Integrin alpha4beta1 promotes monocyte trafficking and angiogenesis in tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Migratory fate and differentiation of blood monocyte subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Adhesion mechanisms regulating the migration of monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Monocyte chemoattractant protein-1--a major contributor to the inflammatory process associated with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Renaming cytokines: MCP-1, major chemokine in pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Chemokines in the pathogenesis of vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Hematopoietic stem cells are uniquely selective in their migratory response to chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Chemokines in neoplastic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Chemokines direct endothelial progenitors into tumor neovessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Mobilized bone marrow cells repair the infarcted heart, improving function and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Adenovirus-mediated hypoxia-targeting cytosine deaminase gene therapy enhances radiotherapy in tumour xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Tumor hypoxia: a target for selective cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Mechanisms of granulocyte colony-stimulating factor-induced hematopoietic progenitor-cell mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

A proliferation switch for genetically modified cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

In vitro and in vivo expansion of hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Hematopoietic stem cell gene therapy: progress toward therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Bcl-2 Engineered MSCs Inhibited Apoptosis and Improved Heart Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Bcl-2 overexpression enhances tumor-specific T-cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Stabilization of cellular properties and differentiation mutilpotential of human mesenchymal stem cells transduced with hTERT gene in a long-term culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Improving cell therapy--experiments using transplanted telomerase-immortalized cells in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

The use of a tropism-modified measles virus in folate receptor-targeted virotherapy of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Targeting virus entry and membrane fusion through specific peptide/MHC complexes using a high-affinity T-cell receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Targeting of adenoviral vectors through a bispecific single-chain antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

An oncolytic adenovirus redirected with a tumor-specific T-cell receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Genetic approaches for antigen-selective cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Genetic engineering of T cell specificity for immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Engineered CD20-specific primary human cytotoxic T lymphocytes for targeting B-cell malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

T cells engrafted with a recombinant anti-CD30 receptor target autologous CD30(+) cutaneous lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Targeted elimination of prostate cancer by genetically directed human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Adoptive T cell therapy for cancer in the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Induction of human T lymphocyte cytotoxicity and inhibition of tumor growth by tumor-specific diabody-based molecules secreted from gene-modified bystander cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Inhibition of tumor growth in vivo by in situ secretion of bispecific anti-CEA x anti-CD3 diabodies from lentivirally transduced human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Human monocytes expressing a CEA-specific chimeric CD64 receptor specifically target CEA-expressing tumour cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Sheep red blood cells armed with anti-CD20 single-chain variable fragments (scFvs) fused to a glycosylphosphatidylinositol (GPI) anchor: a strategy to target CD20-positive tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

A system for the propagation of adenoviral vectors with genetically modified receptor specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Construction of tumor-specific cells expressing a membrane-anchored single-chain Fv of anti-ErbB-2 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Gene therapy to manipulate effector T cell trafficking to tumors for immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Quantitative evaluation of monocyte transmigration into the brain following chemical opening of the blood-brain barrier in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Transduced monocyte/macrophages targeted to murine skin by UV light.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

7 January 2021

Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

7 January 2021

Magnetically responsive erythrocyte ghosts

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

7 January 2021

Migration of Iron Oxide–labeled Human Hematopoietic Progenitor Cells in a Mouse Model: In Vivo Monitoring with 1.5-T MR Imaging Equipment

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

7 January 2021

Erythrocytes as a controlled drug delivery system: Clinical evidences

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

7 January 2021

Surface modified methotrexate loaded erythrocytes for enhanced macrophage uptake

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

7 January 2021

Biodistribution of lymphokine-activated killer (LAK) cells in Wag rats after hepatic-artery or jugular-vein infusion

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

7 January 2021

Delivery of CCL21 to metastatic disease improves the efficacy of adoptive T-cell therapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

7 January 2021

Neutrophil maturation and activation determine anatomic site of clearance from circulation

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

7 January 2021

A Clonogenic Bone Marrow Progenitor Specific for Macrophages and Dendritic Cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

7 January 2021

Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

7 January 2021

Autologous human macrophages and anti-tumour cell therapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

7 January 2021

Fate of mouse macrophages radiolabelled with PKH-95 and injected intravenously

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

7 January 2021

Adoptive transfer of fluorescence-labeled cells shows that resident peritoneal macrophages are able to migrate into specialized lymphoid organs and inflammatory sites in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

7 January 2021

Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

7 January 2021

Importance of recruitment of bone marrow-derived CXCR4+ cells in post-infarct cardiac repair mediated by G-CSF

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

7 January 2021

Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

7 January 2021

Stem cell mobilization by granulocyte-colony-stimulating factor in acute myocardial infarction: lessons from the REVIVAL-2 trial

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

7 January 2021

Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

7 January 2021

Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

7 January 2021

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

7 January 2021

Selective isolation of transiently transfected cells from a mammalian cell population with vectors expressing a membrane anchored single-chain antibody

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

7 January 2021

Temporal correlation between UV radiation locally-inducible tolerance and the sequential appearance of dermal, then epidermal, class II MHC+CD11b+ monocytic/macrophagic cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.38

7 January 2021

Identifiers

DOI

10.1038/GT.2008.38

1 reference

18 August 2017

1 reference

PubMed ID

18369326